GATA4CCL20

N Jannah M Nasir1,2, Samuel Chuah1, Timothy Shuen3

  • 1Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore.

PubMed
概括

肝细胞癌 (HCC) 的进展与减少的GATA4有关,这促进了免疫抑制性瘤微环境. 这涉及C-C 基因化学基因连接物20 (CCL20) 的丰富,影响患者的生存.